Astrazeneca India Private Limited
Astrazeneca India Private Limited is a Private Non-govt company company incorporated in 1986 and based in Tamil Nadu, India. Astrazeneca India Private Limited operates in Acetylene refrigerate gases, manufacturing (NIC 24111) with authorized capital of ₹50.00 Cr and paid-up capital of ₹28.97 Cr. For 2021-22, the company reported revenue of ₹829.16 Cr and profit after tax of ₹107.67 Cr. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +18d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +35d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Astrazeneca India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 971984083 | Kotak Mahindra Bank Ltd(Bank) | ₹15.06 Cr | 12 Mar 2022 | Satisfied |
| 552705397 | HDFC Bank Ltd(Bank) | ₹11.62 Cr | 12 Mar 2022 | Open |
| 777491213 | HDFC Bank Ltd(Bank) | ₹10.65 Cr | 19 Sep 2020 | Open |
| 475022628 | Kotak Mahindra Bank Ltd(Bank) | ₹19.66 Cr | 12 Mar 2019 | Satisfied |
| 789712311 | Kotak Mahindra Bank Ltd(Bank) | ₹16.22 Cr | 12 Mar 2023 | Open |
Charge IDs, lenders & amounts for Astrazeneca India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2021-22 | 2020-21 | 2016-17 | 2015-16 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2021-22 | +7.0% | +73.0% | — | |
| Profit after Tax2021-22 | +14.0% | +47.0% | — | |
| Net Worth2021-22 | -42.0% | +92.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +10.02% | — | +19.87% | +11.44% | — | |||
| 2016-17 | +29.34% | +124.44% | +56.62% | +43.56% | — | |||
| 2020-21 | +9.72% | +15.85% | +19.80% | +11.72% | 0.69 | |||
| 2021-22 | +12.99% | +8.58% | +40.30% | +18.60% | 1.17 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,73,38,480 | 65.01% |
| Institutional Investors | 3 | 17,62,977 | 6.61% |
| Public & Others | 41 | 75,69,763 | 28.38% |
Promoter, institutional & public holding for Astrazeneca India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
66 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.